Validity of Pain Threshold Index in Children
- Conditions
- ElectroencephalographyAnesthesia, General
- Registration Number
- NCT03622242
- Lead Sponsor
- Seoul National University Hospital
- Brief Summary
Comparison of total infused dose of remifentanil between pain threshold index monitoring group and control group
- Detailed Description
Investigators plan to enroll pediatric patients aged between 3 and 12 years old undergoing surgery under general anesthesia with continuous infusion of 2% propofol and remifentanil.
After dividing them into two groups, investigators monitor pain threshold index and wavelet index in test group and adjust remifentanil infusion to maintain both indices in desirable range, while monitoring only wavelet index and adjust remifentanil infusion to maintain wavelet index and conventional vital signs in desirable range in control group.
Investigators compare consumption of remifentanil, time to extubation after surgery, and post-anesthesia care unit length of stay between both groups.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 180
- Children between 3 and 12 years old undergoing orthopedic surgery at extremities under general anesthesia
- History of adverse drug reactions to opioids
- Underlying neurological disease or taking medication for neurologic purpose
- Patients who were transferred to intensive care unit after the surgery
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Remifentanil consumption At the end of anesthesia, total anesthesia time less than 1 day Total amount of infused remifentanil divided by patient's weight and total anesthesia time
- Secondary Outcome Measures
Name Time Method Extubation time At the end of anesthesia, less than 1 hour Elapsed time from end of surgery to extubation
Post-anesthesia care unit length of stay At discharge from post-anesthesia care unit, less than 1 day Length of stay at post-anesthesia care unit
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Seoul National University Hospital
🇰🇷Seoul, Korea, Republic of
Seoul National University Hospital🇰🇷Seoul, Korea, Republic ofHee-Soo Kim, MD, Ph.DContact+82-2-2072-3661dami0605@snu.ac.krSang-Hwan Ji, MD, MSContact+82-2-2072-3661taepoongshin@gmail.com